Quarterly report · Q3
2112.TEDINET S100Q2HZ
Period2022-04-01 → 2022-12-31
Filed2023-02-03
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥21.2bn | 2022-04-01 → 2022-12-31 | Cons. | Net sales |
| Revenue | ¥25.1bn | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥19.3bn | 2021-04-01 → 2021-12-31 | Cons. | Net sales |
| Operating income | ¥549m | 2022-04-01 → 2022-12-31 | Cons. | Operating income |
| Operating income | ¥712m | 2021-04-01 → 2021-12-31 | Cons. | Operating income |
| Ordinary income | ¥560m | 2022-04-01 → 2022-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥906m | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥683m | 2021-04-01 → 2021-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥560m | 2022-04-01 → 2022-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥683m | 2021-04-01 → 2021-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥349m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥609m | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥427m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥349m | 2022-04-01 → 2022-12-31 | Cons. | Profit loss |
| Net income | ¥427m | 2021-04-01 → 2021-12-31 | Cons. | Profit loss |
| Total assets | ¥25.9bn | at 2022-12-31 | Cons. | Assets |
| Total assets | ¥26.1bn | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥26.2bn | at 2021-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥15.0bn | at 2022-12-31 | Cons. | Liabilities |
| Total liabilities | ¥15.7bn | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥10.9bn | at 2022-12-31 | Cons. | Net assets |
| Net assets / equity | ¥10.4bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥10.1bn | at 2021-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥2.6bn | at 2022-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥3.5bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥12.83 | 2022-04-01 → 2022-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.73 | 2022-10-01 → 2022-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥22.43 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥15.74 | 2021-04-01 → 2021-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥7.13 | 2021-10-01 → 2021-12-31d | Cons. | Basic earnings loss per share (5-year summary) |
| Equity ratio | 42.0% | at 2022-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.7% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 38.5% | at 2021-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2022-04-01 → 2022-12-31 | ¥100m |
| Otherother segments | revenue external | 2022-04-01 → 2022-12-31 | ¥88m |
| Otherother segments | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥12m |
| Otherother segments | segment profit | 2022-04-01 → 2022-12-31 | ¥46m |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-12-31 | −¥69m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-12-31 | −¥69m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-12-31 | −¥841m |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥35m |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥354m |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | revenue | 2022-04-01 → 2022-12-31 | ¥19.8bn |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | revenue external | 2022-04-01 → 2022-12-31 | ¥19.7bn |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥21m |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | segment profit | 2022-04-01 → 2022-12-31 | ¥990m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-12-31 | ¥21.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-12-31 | ¥21.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-12-31 | ¥69m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-12-31 | ¥1.4bn |
| Otherother segments | revenue | 2021-04-01 → 2021-12-31 | ¥99m |
| Otherother segments | revenue external | 2021-04-01 → 2021-12-31 | ¥87m |
| Otherother segments | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥12m |
| Otherother segments | segment profit | 2021-04-01 → 2021-12-31 | ¥45m |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-12-31 | −¥63m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-12-31 | −¥63m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-12-31 | −¥868m |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥1.4bn |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥30m |
| jpcrp040300-q3r_E00361-000Biotechnologyreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥386m |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | revenue | 2021-04-01 → 2021-12-31 | ¥17.8bn |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | revenue external | 2021-04-01 → 2021-12-31 | ¥17.8bn |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥21m |
| jpcrp040300-q3r_E00361-000Sugarreportable segment | segment profit | 2021-04-01 → 2021-12-31 | ¥1.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-12-31 | ¥19.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-12-31 | ¥19.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-12-31 | ¥63m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-12-31 | ¥1.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 355
| Item | Context | Value | Unit |
|---|---|---|---|
| Shareholders equity | Prior1YearInstant | 11115000000 | JPY |
| Shareholders equity | CurrentQuarterInstant | 11344000000 | JPY |
| Valuation difference on available for sale securities | Prior1YearInstant | -734000000 | JPY |
| Valuation difference on available for sale securities | CurrentQuarterInstant | -454000000 | JPY |
| Deferred gains or losses on hedges | Prior1YearInstant | 0 | JPY |
| Deferred gains or losses on hedges | CurrentQuarterInstant | -3000000 | JPY |
| Remeasurements of defined benefit plans | Prior1YearInstant | -1000000 | JPY |
| Remeasurements of defined benefit plans | CurrentQuarterInstant | -5000000 | JPY |
| Valuation and translation adjustments | Prior1YearInstant | -736000000 | JPY |
| Valuation and translation adjustments | CurrentQuarterInstant | -462000000 | JPY |
| Net assets | Prior1YearInstant | 10379000000 | JPY |
| Net assets | CurrentQuarterInstant | 10881000000 | JPY |
| Liabilities and net assets | Prior1YearInstant | 26114000000 | JPY |
| Liabilities and net assets | CurrentQuarterInstant | 25897000000 | JPY |
| Net sales | Prior1YTDDuration | 19271000000 | JPY |
| Net sales | CurrentYTDDuration | 21208000000 | JPY |
| Cost of sales | Prior1YTDDuration | 16308000000 | JPY |
| Cost of sales | CurrentYTDDuration | 18418000000 | JPY |
| Gross profit | Prior1YTDDuration | 2963000000 | JPY |
| Gross profit | CurrentYTDDuration | 2790000000 | JPY |
| Selling general and administrative expenses | Prior1YTDDuration | 2251000000 | JPY |
| Selling general and administrative expenses | CurrentYTDDuration | 2241000000 | JPY |
| Operating income | Prior1YTDDuration | 712000000 | JPY |
| Operating income | CurrentYTDDuration | 549000000 | JPY |
| Interest income noi | Prior1YTDDuration | 19000000 | JPY |
| Interest income noi | CurrentYTDDuration | 21000000 | JPY |
| Dividends income noi | Prior1YTDDuration | 112000000 | JPY |
| Dividends income noi | CurrentYTDDuration | 126000000 | JPY |
| Other noi | Prior1YTDDuration | 15000000 | JPY |
| Other noi | CurrentYTDDuration | 31000000 | JPY |
| Non operating income | Prior1YTDDuration | 147000000 | JPY |
| Non operating income | CurrentYTDDuration | 179000000 | JPY |
| Interest expenses noe | Prior1YTDDuration | 76000000 | JPY |
| Interest expenses noe | CurrentYTDDuration | 66000000 | JPY |
| Equity in losses of affiliates noe | Prior1YTDDuration | 70000000 | JPY |
| Equity in losses of affiliates noe | CurrentYTDDuration | 95000000 | JPY |
| Commission fee noe | Prior1YTDDuration | 29000000 | JPY |
| Commission fee noe | CurrentYTDDuration | 5000000 | JPY |
| Other noe | Prior1YTDDuration | 1000000 | JPY |
| Other noe | CurrentYTDDuration | 0 | JPY |
| Non operating expenses | Prior1YTDDuration | 176000000 | JPY |
| Non operating expenses | CurrentYTDDuration | 168000000 | JPY |
| Ordinary income | Prior1YTDDuration | 683000000 | JPY |
| Ordinary income | CurrentYTDDuration | 560000000 | JPY |
| Income before income taxes | Prior1YTDDuration | 683000000 | JPY |
| Income before income taxes | CurrentYTDDuration | 560000000 | JPY |
| Income taxes current | Prior1YTDDuration | 224000000 | JPY |
| Income taxes current | CurrentYTDDuration | 177000000 | JPY |
| Income taxes deferred | Prior1YTDDuration | 30000000 | JPY |
| Income taxes deferred | CurrentYTDDuration | 33000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |